XCELL BIOSCIENCES

xcell-biosciences-logo

Xcell Biosciences is a San Francisco-based life science start-up company that is developing novel and disruptive systems for cell therapy development and production. Their proprietary technology enables fine control of primary cell phenotype and function, enabling an entirely new capability for optimizing efficacy and persistence of immune cell therapies.

#People #Financial #Website #More

XCELL BIOSCIENCES

Social Links:

Industry:
Biotechnology Health Diagnostics Manufacturing Medical Therapeutics

Founded:
2012-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.xcellbio.com

Total Employee:
11+

Status:
Active

Contact:
415-937-0321

Email Addresses:
innovate@xcellbio.com

Total Funding:
39.6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business GoDaddy DNS Google



Current Advisors List

saeid-akhtari_image

Saeid Akhtari Managing Director @ Xcell Biosciences
Board_member

saeid-akhtari_image

Saeid Akhtari Investor / Board Member @ Xcell Biosciences
Board_member
2015-03-01

shaun-rodriguez_image

Shaun Rodriguez Board Member @ Xcell Biosciences
Board_member
2022-01-01

Current Employees Featured

james-lim_image

James Lim
James Lim Founder/CSO @ Xcell Biosciences
Founder/CSO

brian-feth_image

Brian Feth
Brian Feth Founder & CEO @ Xcell Biosciences
Founder & CEO
2012-01-01

Founder


brian-feth_image

Brian Feth

ilya-kupershmidt_image

Ilya Kupershmidt

james-lim_image

James Lim

Investors List

viking-global-investors_image

Viking Global Investors

Viking Global Investors investment in Series B - Xcell Biosciences

casdin-capital_image

Casdin Capital

Casdin Capital investment in Series B - Xcell Biosciences

formic-ventures_image

Formic Ventures

Formic Ventures investment in Series B - Xcell Biosciences

dynamk-capital_image

Dynamk Capital

Dynamk Capital investment in Series B - Xcell Biosciences

laboratory-corporation-of-america_image

LabCorp

LabCorp investment in Series B - Xcell Biosciences

viking-global-investors_image

Viking Global Investors

Viking Global Investors investment in Series A - Xcell Biosciences

nimble-vc_image

Nimble Ventures

Nimble Ventures investment in Funding Round - Xcell Biosciences

illumina-accelerator_image

Illumina Accelerator

Illumina Accelerator investment in Convertible Note - Xcell Biosciences

Official Site Inspections

http://www.xcellbio.com Semrush global rank: 6.02 M Semrush visits lastest month: 1.36 K

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Xcell Biosciences"

xcellbio - LinkedIn

Xcellbio | 5,904 followers on LinkedIn. Improving therapeutic performance for predictive clinical outcomes through in vitro microenvironment control. | Xcell Biosciences (xcellbio) is a San ...See details»

Xcell Biosciences - Crunchbase Company Profile

Contact Email innovate@xcellbio.com Phone Number 415-937-0321 Xcell Biosciences is a San Francisco-based life science start-up company that is …See details»

AmplifyBio and Xcell Biosciences Announce Partnership to …

May 20, 2024 SAN FRANCISCO & SOUTH SAN FRANCISCO, Calif., May 20, 2024--Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene …See details»

AmplifyBio and Xcell Biosciences Announce Partnership to …

May 20, 2024 SAN FRANCISCO & SOUTH SAN FRANCISCO, Calif.--Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing …See details»

Xcell Biosciences - Overview, News & Similar companies - ZoomInfo

Apr 20, 2022 SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced …See details»

Xcell Biosciences Expands AmplifyBio Collaboration with Unique …

Oct 2, 2024 Xcellbio and AmplifyBio have an ongoing collaboration aimed at streamlining and improving the manufacturing process for engineered T-cell receptor (TCR) therapies targeting …See details»

Xcell Biosciences - 2025 Company Profile - Tracxn

Mar 9, 2025 Xcellbio Announces $27.5 Million Series B FinancingBusiness Wire • Jan 19, 2022 • Xcell Biosciences, Casdin Capital, Dynamk Capital, Formic Ventures and 3 others Get curated …See details»

Xcell Biosciences - Craft

Xcell Biosciences is a company that specializes in cell therapy and platform technology development solutions. It offers AVATAR, a system for the cultivation of primary human cells; …See details»

xcellbio - Products, Competitors, Financials, Employees, …

Xcellbio focuses on primary cell control solutions within the immunotherapy market. The company offers primary cell control systems, reagent kits, software, and standardized protocols to …See details»

Xcellbio and AmplifyBio partner to advance cell-therapy …

Oct 8, 2024 Contract development and manufacturing organization (CDMO) AmplifyBio has gained access to Xcellbio’s Avatar Foundry system, enabling small-scale workflows. The …See details»

Xcellbio Announces Partnership with Planet Innovation to Develop …

19 hours ago MELBOURNE, Australia, March 25, 2025--Xcell Biosciences Australia Pty Ltd (Xcellbio), an Australian affiliate of the San Francisco-based instrumentation company focused …See details»

Labcorp Enhances Cell and Gene Therapy Development Support

Apr 19, 2022 The projects included in the collaboration will use Xcellbio’s AVATAR incubator system to grow and expand research-grade CAR-T cell material used to attack cancer cells. ...See details»

AmplifyBio and Xcell Biosciences Announce Partnership to …

May 20, 2024 Xcellbio is driven by its mission to enhance the performance and safety of cell and gene-based therapies through the design and development of revolutionary technology …See details»

Xcell Biosciences Expands AmplifyBio Collaboration with

Oct 2, 2024 SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced …See details»

Xcell Biosciences Announces Collaboration with ElevateBio to …

Jan 11, 2024 ElevateBio becomes first participant in the AVATAR Foundry beta programJanuary 11, 2024 08:05 AM Eastern Standard TimeSAN FRANCISCO--Xcell Biosciences, Inc. …See details»

AmplifyBio and Xcell Biosciences: An Uncommonly Great …

May 21, 2024 Xcellbio and AmplifyBio have partnered to enhance the development and manufacturing of engineered T-cell receptor (TCR) therapies for solid tumors. The …See details»

Xcellbio Announces Partnership with Planet Innovation to Develop …

1 day ago Xcellbio is driven by its mission to enhance the performance and safety of cell and gene-based therapies through the design and development of revolutionary technology …See details»

Xcell Biosciences Expands AmplifyBio Collaboration with Unique …

Oct 3, 2024 SAN FRANCISCO — October 2, 2024 – Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced …See details»

Xcellbio Announces Partnership with Planet Innovation to Develop …

8 hours ago The company has worked with Xcellbio during the past 2 years to develop the AVATAR Foundry instrument from its innovation headquarters in Melbourne. Planet Innovation …See details»

Xcell Biosciences Strengthens Cell and Gene Therapy …

Apr 1, 2024 Longstanding partnership deepens with new financing, beta access to clinical manufacturing instruments, and AACR data presentationsApril 1, 2024Xcell Biosciences Inc. …See details»

linkstock.net © 2022. All rights reserved